Parzeczew, Poland

Magdalena Lukasiak

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bioinfobank Sp. Z O. O.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Magdalena Lukasiak. Retrieved from https://idiyas.com/inventor/magdalena-lukasiak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Magdalena Lukasiak

Introduction

Magdalena Lukasiak is a prominent inventor based in Parzeczew, Poland. She has made significant strides in the field of biotechnology, particularly in the development of cytotoxins for medical applications. Her work focuses on enhancing the efficacy of treatments for proliferating cells, especially tumor cells.

Latest Patents

Magdalena holds a patent for a recombinant cytotoxin, which includes a method of producing it. The invention involves modifying proteinaceous toxins by adding an NLS motif. This innovative cytotoxin is designed to facilitate the selective elimination of proliferating cells, making it a valuable tool in cancer treatment.

Career Highlights

Magdalena is associated with Bioinfobank Sp. z o.o., where she contributes her expertise in biotechnology and innovation. Her work has garnered attention for its potential impact on therapeutic strategies in oncology.

Collaborations

She collaborates with notable colleagues, including Anna Bujko and Jaroslaw Dastych, who share her commitment to advancing medical science through innovative research.

Conclusion

Magdalena Lukasiak's contributions to the field of biotechnology exemplify the importance of innovation in developing effective treatments for cancer. Her work continues to inspire advancements in medical research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…